Risk of Preterm or Small-for-Gestational-Age Birth after Influenza Vaccination during Pregnancy: Caveats When Conducting Retrospective Observational Studies

American Journal of Epidemiology

Volumn 184, Issue 3, 2016, Pages 176-186

  Vazquez Benitez, Gabriela ^a   Kharbanda, Elyse O ^a   Naleway, Allison L ^b   Lipkind, Heather ^c   Sukumaran, Lakshmi ^d,e   McCarthy, Natalie L ^d   Omer, Saad B ^f   Qian, Lei ^g   Xu, Stanley ^g   Jackson, Michael L ^h   Vijayadev, Vinutha ^g   Klein, Nicola P ⁱ   Nordin, James D ^a  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e EMORY UNIVERSITY   (United States)

^f EMORY UNIVERSITY   (United States)

^g KAISER PERMANENTE   (United States)

^h GROUP HEALTH RESEARCH INSTITUTE   (United States)

ⁱ DIVISION OF RESEARCH   (United States)

Author keywords

biases; birth outcomes; monovalent H1N1 influenza vaccine safety; pregnancy; preterm delivery; small for gestational age

Indexed keywords

INFLUENZA VACCINE;

AGE STRUCTURE; AVIAN INFLUENZA; CONFIDENCE INTERVAL; EPIDEMIOLOGY; MENTAL HEALTH; PREGNANCY; REPRODUCTIVE STATUS; RISK ASSESSMENT; SAMPLING BIAS; SPATIOTEMPORAL ANALYSIS; VACCINATION; VACCINE; WOMENS HEALTH;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; COMORBIDITY; DRUG EFFECTS; FACTUAL DATABASE; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; MATERNAL AGE; NEWBORN; POSTMARKETING SURVEILLANCE; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVALENCE; PROCEDURES; PROPENSITY SCORE; RISK ASSESSMENT; STANDARDS; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES; VIROLOGY; YOUNG ADULT;

UNITED STATES;

ADULT; BIAS (EPIDEMIOLOGY); COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MATERNAL AGE; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; PREMATURE BIRTH; PREVALENCE; PRODUCT SURVEILLANCE, POSTMARKETING; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84982920430     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kww043     Document Type: Article

References (51)

1. Omer SB, Goodman D, Steinhoff MC, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med. 2011;8(5):e1000441.
2. Richards JL, Hansen C, Bredfeldt C, et al.Neonatal outcomes after antenatal influenza immunization during the 2009H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis. 2013;56(9):1216-1222.
3. Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health. 2012;102(6):e33-e40.
4. Dodds L, Macdonald N, Scott J, et al. The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can. 2012;34(8):714-720.
5. Heikkinen T, Young J, van Beek E, et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol. 2012;207(3): 177.e1-177.e8.
6. Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA. 2012; 308(2):165-174.
7. Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr. 2014;164(5):1051-1057.
8. Kallen B, Olausson PO. Vaccination against H1N1 influenza with Pandemrix® during pregnancy and delivery outcome: a Swedish register study. BJOG. 2012;119(13):1583-1590.
9. Moro PL, Museru OI, Broder K, et al. Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women. Obstet Gynecol. 2013;122(6):1271-1278.
10. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA. 2014;312(18): 1897-1904.
11. Kharbanda EO,Vazquez-BenitezG, Lipkind H, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013;122(3):659-667.
12. Nordin JD, Kharbanda EO, Benitez GV, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519-525.
13. Kharbanda EO, Parker ED, Nordin JD, et al. Influenza and pertussis vaccination coverage among privately insured women of reproductive age. Matern Child Health J. 2013;17(9):1631-1637.
14. Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
15. Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS One. 2011;6(7):e22618.
16. Strand LB, Barnett AG, Tong S. Methodological challenges when estimating the effects of season and seasonal exposures on birth outcomes. BMC Med Res Methodol. 2011;11:49.
17. Savitz D, Fell D, Ortiz J, et al. Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine. 2015;33(47):6430-6435.
18. Daniel S, Koren G, Lunenfeld E, et al. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure. Am J Obstet Gynecol. 2015;212(3):307.e1-307.e6.
19. Rubinstein F, Micone P, Bonotti A, et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ. 2013;346:f393.
20. Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011; 127(suppl 1):S45-S53.
21. Hornbrook MC, Whitlock EP, Berg CJ, et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res. 2007;42(2): 908-927.
22. Naleway AL, Gold R, Kurosky S, et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 2013;31(27):2898-2903.
23. Oken E, Kleinman KP, Rich-Edwards J, et al. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6.
24. Andrade SE, Scott PE, Davis RL, et al. Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf. 2013;22(1):7-15.
25. Kotelchuck M. The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight. Am J Public Health. 1994;84(9):1486-1489.
26. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health. 1994;84(9):1414-1420.
27. Little R, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. New York, NY: John Wiley; 2002.
28. World Health Organization. FluNet. Geneva, Switzerland: World Health Organization. http://www.who.int/influenza/gisrs-laboratory/flunet/en/.
29. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ. 2005;330(7497):960-962.
30. Fell DB, Platt RW, Lanes A, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG. 2015;122(1):17-26.
31. Legge A, Dodds L, MacDonald NE, et al. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. Can Med Assoc J. 2014;186(4):E157-E164.
32. Louik C, Ahrens K, Kerr S, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine. 2013; 31(44):5033-5040.
33. Cantu J, Biggio J, Jauk V, et al. Selective uptake of influenza vaccine and pregnancy outcomes. J Matern Fetal Neonatal Med. 2013;26(12):1207-1211.
34. Oppermann M, Fritzsche J, Weber-Schoendorfer C, et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30(30): 4445-4452.
35. Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol. 2012;207(3 suppl):S33-S37.
36. Källén B. The problem of confounding in studies of the effect of maternal drug use on pregnancy outcome. Obstet Gynecol Int. 2012;2012:148616.
37. Lee SJ, Steer PJ, Filippi V. Seasonal patterns and preterm birth: a systematic review of the literature and an analysis in a London-based cohort. BJOG. 2006;113(11):1280-1288.
38. Xu R, Luo Y, Glynn R, et al. Time-dependent propensity score for assessing the effect of vaccine exposure on pregnancy outcomes through pregnancy exposure cohort studies. Int J Environ Res Public Health. 2014;11(3):3074-3085.
39. Savitz DA, Hertz-Picciotto I, Poole C, et al. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev. 2002;24(2):91-101.
40. Kramer MS, Zhang X, Platt RW. Analyzing risks of adverse pregnancy outcomes. Am J Epidemiol. 2014;179(3): 361-367.
41. S O'Neill M, Hertz-Picciotto I, Pastore LM, et al. Have studies of urinary tract infection and preterm delivery used the most appropriate methods? Paediatr Perinat Epidemiol. 2003;17(3): 226-233.
42. Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013;31(44): 5026-5032.
43. Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368:333-340.
44. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ. 2014;349: g4219.
45. Ludvigsson JF, Zugna D, Cnattingius S, et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol. 2013;28(7):579-588.
46. Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463-468.
47. Munoz FM, Greisinger AJ, Wehmanen OA, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2005;192(4):1098-1106.
48. Hubka TA, Wisner KP, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention. Vaccinations recommended during pregnancy and breastfeeding. J Am Osteopath Assoc. 2011;111(10 suppl 6): S23-S30.
49. Ovesen PG, Jensen DM, Damm P, et al. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J Matern Fetal Neonatal Med. 2015;28(14): 1720-1724.
50. Toh S, García Rodríguez LA, Hernán MA. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf. 2011;20(8):849-857.
51. Mustafa G, David RJ. Comparative accuracy of clinical estimate versus menstrual gestational age in computerized birth certificates. Public Health Rep. 2001;116(1):15-21.